CareCloud, Inc.

Listed Company

CCLDCIK 0001582982NasdaqAcceleratedSmaller ReportingServices-Prepackaged SoftwareDelawareFY ends Dec 31

Period

FY 2025

Revenue

$120.50M

Net Income

$10.80M

Total Assets

$87.60M

Equity

$59.51M

Shares Out

42.49M

Op. Cash Flow

$28.56M

Business

CareCloud, Inc. provides technology-enabled services and generative AI solutions focused on healthcare revenue cycle management. It offers revenue cycle management services, medical coding and credentialing, a claims clearinghouse, cloud-based software including EHR and practice management, AI-powered cirrusAI tools, patient experience management, business intelligence, telemedicine, remote monitoring, and professional IT services and staffing. Its operations are organized into technology-enabled RCM, cloud-based software, digital health, IT professional services & staffing, and medical practice management segments. CareCloud serves healthcare providers ranging from small practices to large physician groups, hospitals and health systems across the United States through direct sales, partner channels and digital platforms.

Summary from filing dated 2025-03-13

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
NET REVENUE	120	111	117	139	140
Direct operating costs	64	61	71	84	—
Selling and marketing	5	6	10	10	9
General and administrative	18	16	21	24	24
Research and development	6	4	5	4	4
Depreciation and amortization	15	14	14	12	12
Lease termination and restructuring costs	154,000	596,000	—	—	—
Total operating expenses	109	102	164	132	136
Operating income (loss)	11	9	−47	7	4
Interest income	206,000	88,000	154,000	41,000	15,000
Interest expense	−287,000	−900,000	−1	−405,000	−455,000
Other expense - net	−265,000	−298,000	−883,000	−637,000	−96,000
INCOME BEFORE PROVISION FOR INCOME TAXES	11	8	−49	6	3
Income tax provision	199,000	160,000	−364,000	177,000	157,000
NET INCOME	11	8	−49	5	3
Preferred stock dividend	7	12	16	—	—
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS	4	−4	−64	−10	−11
Net income (loss) per share: basic	0.1	−0.28	−4.11	−0.67	−0.77
Net income (loss) per share: diluted	0.1	−0.28	−4.11	−0.67	—
Weighted-average common shares used to compute basic income (loss) per share	38	16	16	15	15
Weighted-average common shares used to compute diluted income (loss) per share	38	16	16	15	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash	3	5	3	12	—
Restricted cash	500,000	—	—	—	1
Accounts receivable - net	15	13	12	15	17
Contract asset	4	4	5	4	5
Inventory	507,000	574,000	465,000	381,000	503,000
Current assets - related party	16,000	16,000	16,000	16,000	—
Prepaid expenses and other current assets	3	2	2	3	3
Total current assets	26	25	23	35	36
Property and equipment - net	8	5	5	5	5
Operating lease right-of-use assets	3	3	4	5	7
Intangible assets - net	19	19	25	30	31
Goodwill	31	19	19	61	61
Other assets	569,000	507,000	641,000	838,000	981,000
TOTAL ASSETS	88	72	78	136	141
Accounts payable	7	5	6	6	6
Accrued compensation	4	2	3	4	4
Accrued expenses	6	5	5	4	5
Operating lease liability (current portion)	927,000	1	2	2	4
Deferred revenue (current portion)	4	1	1	1	1
Notes payable (current portion)	728,000	310,000	292,000	319,000	344,000
Contingent consideration (current portion)	909,000	—	—	—	1
Dividend payable	668,000	5	5	4	4
Total current liabilities	24	20	23	22	30
Notes payable	441,000	26,000	37,000	13,000	20,000
Contingent consideration	232,000	—	—	—	—
Operating lease liability	2	2	3	3	5
Deferred revenue	809,000	387,000	256,000	342,000	341,000
Total liabilities	28	22	36	34	43
COMMITMENTS AND CONTINGENCIES (NOTE 11)	—	—	—	—	—
Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 984,530 and 4,526,231 shares at December 31, 2025 and December 31, 2024, respectively. Series B, issued and outstanding 1,511,372 shares at December 31, 2025 and December 31, 2024.	2,000	6,000	6,000	6,000	5,000
Common stock, $0.001 par value - authorized 85,000,000 and 35,000,000 shares at December 2025 and 2024, respectively. Issued 43,178,748 and 16,997,035 shares at December 31, 2025 and December 31, 2024, respectively. Outstanding 42,437,949 and 16,256,236 shares at December 31, 2025 and December 31, 2024, respectively	43,000	17,000	17,000	16,000	16,000
Additional paid-in capital	120	121	121	131	131
Accumulated deficit	−56	−67	−74	−26	−31
Accumulated other comprehensive loss	−4	−4	−4	−3	−2
Less: 740,799 common shares held in treasury, at cost at December 31, 2025 and December 31, 2024	−662,000	−662,000	—	—	—
Total shareholders equity	60	50	42	102	98
TOTAL LIABILITIES AND SHAREHOLDERS EQUITY	88	72	78	136	141

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	15	14	15	12	13
Lease amortization	2	2	2	3	4
Provision for expected credit losses	286,000	334,000	454,000	740,000	890,000
Foreign exchange loss (gain)	109,000	−130,000	790,000	610,000	−16,000
Interest accretion	310,000	592,000	688,000	596,000	857,000
Stock-based compensation expense	454,000	115,000	5	5	5
Accounts receivable	−408,000	−1	2	1	−620,000
Contract asset	754,000	760,000	−695,000	326,000	−620,000
Inventory	67,000	−109,000	−84,000	122,000	−104,000
Other assets	−1	673,000	682,000	619,000	921,000
Accounts payable and other liabilities	1	−5	−3	−7	−10
Deferred revenue	−825,000	−37,000	−92,000	302,000	−72,000
Net cash provided by operating activities	29	21	15	21	13
Purchases of property and equipment	−5	−2	−3	−3	−3
Capitalized software and other intangible assets	−3	−6	−9	−9	—
Payments for acquisitions	−17	—	—	—	−13
Net cash used in investing activities	−25	−7	−12	−12	−23
Preferred stock dividends paid	−6	—	−14	−15	−14
Payment of contingent obligations	−124,000	—	—	−1	—
Payment of tax withholding obligations on stock issued to employees	−24,000	−579,000	−2	−1	−2
Proceeds from term-loan borrowings	1	—	—	—	—
Repayments of notes payable	−620,000	−677,000	−888,000	−1	−1
Proceeds from line of credit	9	—	15	26	26
Repayment of line of credit	−9	−10	−13	−26	−18
Net cash used in financing activities	−6	−11	−13	−8	−519,000
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND RESTRICTED CASH	57,000	−166,000	469,000	225,000	−254,000
NET (DECREASE) INCREASE IN CASH AND RESTRICTED CASH	−2	2	−9	2	−11
Conversion of preferred stock and accrued dividends to common stock	2	—	—	—	—
Dividends declared, not paid	668,000	5,000	5	4	4
Purchase of prepaid insurance with assumption of note	—	685,000	656,000	695,000	967,000
Reclass of deposits for property and equipment placed in service	—	296,000	—	—	—
Income taxes	246,000	157,000	144,000	153,000	282,000
Interest	226,000	677,000	927,000	162,000	103,000

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro